HELX 31.90 Franklin Genomic Advancements ETF
| Range: | 25.26-33.976 | Vol Avg: | 2126 | Last Div: | 0 | Changes: | 0.2 |
| Beta: | 1.11 | Cap: | 0.01B | Currency: | USD | Exchange: | AMEX |
| Sector: | Financial Services | IPO: | Thu Feb 27 2020 | Empoloyees: | |||
| CUSIP: | 35473P520 | CIK: | 0001655589 | ISIN: | US35473P5200 | Country: | US |
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow